1. Home
  2. REGN vs FDX Comparison

REGN vs FDX Comparison

Compare REGN & FDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$786.23

Market Cap

79.4B

Sector

Health Care

ML Signal

HOLD

Logo FedEx Corporation

FDX

FedEx Corporation

HOLD

Current Price

$383.99

Market Cap

85.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
FDX
Founded
1988
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.4B
85.7B
IPO Year
1995
1997

Fundamental Metrics

Financial Performance
Metric
REGN
FDX
Price
$786.23
$383.99
Analyst Decision
Buy
Buy
Analyst Count
23
21
Target Price
$815.04
$335.33
AVG Volume (30 Days)
657.5K
1.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.49%
1.52%
EPS Growth
8.19
N/A
EPS
41.48
7.50
Revenue
$5,872,227,000.00
$65,450,000,000.00
Revenue This Year
$11.69
$6.46
Revenue Next Year
$10.12
$4.12
P/E Ratio
$18.54
$50.99
Revenue Growth
20.82
N/A
52 Week Low
$476.49
$194.30
52 Week High
$821.11
$392.86

Technical Indicators

Market Signals
Indicator
REGN
FDX
Relative Strength Index (RSI) 53.95 70.13
Support Level $737.04 $220.40
Resistance Level $818.06 N/A
Average True Range (ATR) 21.81 9.16
MACD -1.05 -2.13
Stochastic Oscillator 55.37 71.40

Price Performance

Historical Comparison
REGN
FDX

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About FDX FedEx Corporation

FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In fiscal 2025, the firm's Federal Express segment-which houses the core package delivery operations-made up 86% of total revenue, with 10% coming from FedEx Freight, its asset-based less-than-truckload shipping segment. The remainder came from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016, boosting its presence across Europe. TNT was previously the fourth-largest global parcel delivery provider.

Share on Social Networks: